Skip to main content
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. — Investor Relations & Filings

Ticker · MRKR ISIN · US57055L1070 US Manufacturing
Open in API
Filings indexed 899 across all filing types
Latest filing 2014-05-20 Capital/Financing Update
Country US United States of America
Listing US MRKR

About Marker Therapeutics, Inc.

https://markertherapeutics.com/

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematologic malignancies and solid tumors. The company's core technology is its Multi-Antigen Recognizing (MAR) T cell platform, which utilizes natural, non-genetically modified T cells to recognize and kill heterogeneous tumors. This approach is designed to provide durable anti-tumor responses with a favorable safety profile. Its lead product candidate, MT-601, recognizes six tumor-specific antigens and is being evaluated in a Phase 1 study for patients with lymphoma who have relapsed or are ineligible for anti-CD19 CAR-T cell therapy. The technology was originally developed at Baylor College of Medicine.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2014
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC under the Securities Act of 1933. It is a registration statement used by companies to register securities for sale to the public, often as part of a shelf registration allowing multiple offerings over time. The text includes details about the registration, the securities to be offered (common stock), the prospectus summary, risk factors, and other information typical of a registration statement. It is not an annual report, earnings release, or any other financial report. It is also not a proxy statement, voting results, or management information. The document is clearly a capital markets filing related to financing activities, specifically a securities registration for offering shares. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is the registration statement itself, not just an announcement or a brief notice, so it is not RPA or RNS. Confidence is high given the clear identification of Form S-3 and the nature of the content.
2014-05-20 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Q1 2014
2014-05-20 English
Regulatory Filings 2014
Regulatory Filings Classification · 100% confidence The document is a Form 12B-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2014, due to administrative delays. The document does not contain the actual financial data or the report itself but is merely a notification about the delay in filing the 10-Q report. The document length is short (2111 characters) and fits the pattern of a regulatory filing notification rather than the report itself. According to the rules, such notifications should be classified as Regulatory Filings (RNS) rather than as the actual 10-Q report or any other financial report type.
2014-05-15 English
Annual Report 2013
Annual Report FY 2013
2014-04-16 English
Annual Report 2013
Annual Report FY 2013
2014-04-15 English
Regulatory Filings 2014
Regulatory Filings Classification · 100% confidence The document is a Form 12B-25, which is a Notification of Late Filing for an Annual Report on Form 10-K. It states that the 10-K for the fiscal year ended December 31, 2013 has not been completed due to administrative delays and will be filed soon. The document does not contain the actual 10-K report or financial data, but is merely a notification of delay. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document and not the report itself.
2014-04-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.